2.27
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMRA?
Forum
Prognose
Aktiensplit
Biomerica Inc Aktie (BMRA) Neueste Nachrichten
Biomerica (BMRA) finance chief discloses four stock option awards - Stock Titan
Biomerica Raises $2.23 Million as Quarterly Sales Rise 17% - Orange County Business Journal
BRC Group Holdings, Inc. Buys Biomerica Inc (BMRA) -- Shares Look 12% Overvalued on GF Value - GuruFocus
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com Nigeria
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock - Investing.com
Biomerica net loss hits USD 3.8M in 2026 - Medical Buyer
BRC Group Holdings Secures 10.03% Activist Stake in BIOMERICA INC (NASDAQ: BMRA) with $736,128 Investment - Kalkine Media
Biomerica reports fiscal 2026 revenue and product updates - grafa.com
Biomerica Reports Q4 Results - Orange County Business Journal
Biomerica Q4 net loss narrows 27%, revenue up 17% to $875K - scanx.trade
Biomerica Reports Fiscal 2026 Fourth-Quarter Sales Growth, Improved Full-Year Loss and Advances in inFoods IBS Commercialization - Quiver Quantitative
BIOMERICA INC FY 2026: Revenue $4.45M, EPS $(1.30) — 10-K Summary - TradingView
Biomerica : Annual Report for Fiscal Year Ending May 31, 2026 (Form 10-K) - marketscreener.com
Biomerica announces USD 2.23M financing - Medical Buyer
Biomerica, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
B. Riley joins Biomerica (BMRA) as key investor and deal advisor - Stock Titan
Biomerica Inc. (BMRA) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
BRC Group Holdings Secures Board Representation at Biomerica with 10.03% Stake - TradingView
Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com India
Biomerica (BMRA) director joins $1.60 private placement buy - Stock Titan
Biomerica (BMRA) director adds 6,250 shares in private deal - Stock Titan
Biomerica (NASDAQ: BMRA) director adds shares in $1.60 private placement - Stock Titan
Biomerica (NASDAQ: BMRA) director lifts stake to 73,542 shares - Stock Titan
Biomerica (NASDAQ: BMRA) CEO adds 31,250 shares in private placement - Stock Titan
Biomerica Inc. (BMRA) Key Financial Ratios – Valuation, Profitability & More - Value Research
Biomerica raises $2.23M in private placement led by B. Riley - Dealroom
Biomerica raises $2.23 million in private placement at $1.60 - Investing.com
Biomerica Announces $2.23 Million Private Placement at $1.60 per Share and Engages B. Riley to Review Strategic Alternatives - Moomoo
Biomerica CEO Zackary S. Irani reports acquisition of $50,000 common shares - Bitget
Biomerica, Inc. Hires B. Riley to Consider Strategic Options - marketscreener.com
Biomerica Completes Private Placement of Equity Securities - TipRanks
Biomerica Enters Securities Purchase Agreement for Private Placement With Investors - TradingView
Biomerica (NASDAQ: BMRA) grants B. Riley board designee in $2.23M raise - Stock Titan
Biomerica, Inc. announced that it has received $2.229928 million in funding - marketscreener.com
Biomerica (BMRA) Chart: Ends Up by 4.35% at $1.68; Range View: the Current Price Sits Inside the Supplied Technical Range in the Latest ReadingIsland Reversal - dars.gov.et
Biomerica (BMRA) Watch: Moves 1.58% Higher to $1.61 in Latest Trading; Immediate View: the Supplied Trading Band Runs From $1.53 to $1.69 in the Available RecordIchimoku Kumo Twist - vinanet.vn
Biomerica, Inc. announced that it expects to receive $2.229928 million in funding - marketscreener.com
BMRA Q2 2026 Earnings: EPS Loss of $0.44 Highlights Cost-Heavy Development PhaseEarnings Season Review - vinanet.vn
Biomerica (BMRA) Slips 2.47% to $1.58 as Shares Test Key Support ZonePassive Flow - dars.gov.et
Biomerica (BMRA) Advances 3.18% to $1.62, Pressing Against Key Resistance at $1.70Volume Rate Change - Vinanet
Biomerica Inc (BMRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biomerica (BMRA) Edges Lower to $1.5: Navigating Support and ResistanceStock Picks - vinanet.vn
BMRA Q2 2026 Earnings: Loss of $0.44 Per Share Amid Thin DisclosureBook Value Growth - vinanet.vn
Biomerica Inc (BMRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biomerica (BMRA) Q2 2026 Earnings: Net Loss Per Share of -$0.44 Highlights Challenging QuarterNet Profit Margin - dars.gov.et
BMRA|Biomerica Inc|Price:1.620|Chg%:+0.035 - TradingKey
Biomerica Inc (BMRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biomerica Inc (BMRA) Income Statement - tradingkey.com
Biomerica Inc (BMRA) Institutional Confidence - TradingKey
Biomerica Inc (BMRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
BMRA|Biomerica Inc|Price:1.540|Chg%:-0.080 - TradingKey
Biomerica Inc (BMRA) Balance Sheet - TradingKey
Biomerica (BMRA) Holds Near Support After Minor DeclineDealer Gamma - vinanet.vn
BMRA|Biomerica Inc|Price:1.585|Chg%:+0.015 - TradingKey
Biomerica, Inc. Revenue Breakdown – NASDAQ:BMRA - TradingView
Biomerica Inc. (BMRA) Edges Higher in Quiet TradingDiamond Pattern - dars.gov.et
Biomerica Inc. (BMRA) Edges Higher in Low-Volume Trading, Testing Key Resistance ZoneMAMA Signal - dars.gov.et
Biomerica (BMRA) Holds Key Support After Marginal DeclineWeak Sell Signals - vinanet.vn
BMRA Q2 2026 Earnings: EPS Misses as Revenue Data Unavailable, Stock Rebounds SlightlyEarnings Deceleration Risk - vinanet.vn
BMRA Q2 2026 Earnings: Reported Loss of -$0.44 per Share; Stock Gains $1.52Analyst Consensus Shift - vinanet.vn
BMRA Q2 2026 Earnings: Net Loss of $0.44 per Share; Stock Declines 3.55%Analyst Consensus Shift - vinanet.vn
BMRABiomerica Inc Short Interest - Finviz
Biomerica Inc. (BMRA) Q2 2026 Earnings: Negative EPS as Company Continues Operational FocusQuarterly Earnings Report - dars.gov.et
BMRA Q2 2026 Earnings: Diagnostics Firm Posts Wider-Than-Expected Loss as Stock RisesProfitability Analysis - dars.gov.et
Price to sales forward of Biomerica, Inc. – NASDAQ:BMRA - TradingView
Enterprise value to EBITDA forward of Biomerica, Inc. – NASDAQ:BMRA - TradingView
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):